Milnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) primarily indicated for the management of fibromyalgia and the treatment of major depressive disorder. By inhibiting the… Read more



![Chemical structure of (1R,5S)-1-phenyl-3-oxabicyclo[3.1.0]hexan-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F98647-52-8-1R5S-1-phenyl-3-oxabicyclo3.1.0hexan-2-one.png&w=3840&q=75)


![Chemical structure of (1S,5R)-1-Phenyl-3-azabicyclo[3.1.0]hexan-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F810696-16-3-1S5R-1-Phenyl-3-azabicyclo3.1.0hexan-2-one.png&w=3840&q=75)
![Chemical structure of 1-Phenyl-3-azabicyclo[3.1.0]hexan-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F153275-06-0-1-Phenyl-3-azabicyclo3.1.0hexan-2-one.png&w=3840&q=75)
![Chemical structure of 1-Phenyl-3-oxabicyclo[3.1.0]hexan-2-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F63106-93-4-1-Phenyl-3-oxabicyclo3.1.0hexan-2-one.png&w=3840&q=75)




![Chemical structure of Cyclopropanecarboxamide, 2-[(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-N,N-diethyl-1-phenyl-;](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1100753-09-0-Cyclopropanecarboxamide-2-13-dihydro-13-dioxo-2H-isoindol-2-ylmethyl-NN-diethyl-1-phenyl.png&w=3840&q=75)









![Chemical structure of Rel-(1R,2S)-2-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl]-N,N-diethyl-1-phenylcyclopropanecarboxamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F105310-75-6-Rel-1R2S-2-13-Dihydro-13-dioxo-2H-isoindol-2-ylmethyl-NN-diethyl-1-phenylcyclopropanecarboxamide.png&w=3840&q=75)


Milnacipran is a selective serotonin and norepinephrine reuptake inhibitor (SNRI) primarily indicated for the management of fibromyalgia and the treatment of major depressive disorder. By inhibiting the reuptake of these neurotransmitters, the drug helps modulate pain perception and mood stability. This category contains a comprehensive collection of Milnacipran reference standards, including the active pharmaceutical ingredient, its enantiomers, and a wide array of pharmacopeial and non-pharmacopeial impurities. Laboratories utilize these high-quality compounds, including synthetic intermediates, degradation products, and stable isotope labelled versions, for critical analytical testing and method validation. These materials are essential for accurate impurity profiling and robust quality control procedures throughout the pharmaceutical development and manufacturing lifecycle. By providing structurally characterized standards, this collection supports rigorous stability studies and ensures compliance with global regulatory guidelines for therapeutic safety and efficacy.